Eiko Lifesciences Ltd — Updates, 14-05-2025: Company Update

Eiko Lifesciences Limited has announced its Annual Secretarial Compliance Report confirming full adherence to applicable corporate governance standards and SEBI regulations during the year. There were no director disqualifications, regulatory actions, or non-compliances noted. The company maintains updated policies, a functional website, and conducts board and committee evaluations as required. Auditor interactions were smooth with no audit concerns or resignations affecting compliance. Insider trading controls, including a Structured Digital Database, are firmly in place and functioning effectively. This reflects robust governance and regulatory discipline, supporting shareholder confidence.